Pfizer’s (PFE) interest in Seagen (SGEN) marks the second time in a year the cancer-focused biotech has been an acquisition target by a major pharmaceutical player in the cancer space. Seagen wa...
Tag: Merck
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
New Questions Arise For U.S. Businesses In China After “Jarring” End To Zero-Covid Policy
A woman pushes luggage near a check-in counter at Beijing Capital International Airport in Beijing, … [+] China, on Friday, Dec. 30, 2022. China could see as many as 25,000 deaths a day from Cov...
Merck Rallies to Best Year Since 1995 on Strong Sales, Drug Data
(Bloomberg) — Merck & Co. notched its best yearly gain in more than two decades, making it the top-performing drugmaker in the S&P 500 in 2022 as investors rewarded the company for stron...
13 dividend hikes to watch for this week: McCormick, Merck
Companies often establish a pattern of hiking dividends at the same time each year, giving investors a reliable cash influx and enticing them to stick around for the long term. With help from StreetIn...
Stock Market Looks Poised to Rally as Bond Yield Falls
Text size Michael Nagle/Bloomberg The worst may be over for the stock market. Key equity indexes continued their autumn rally, and there could be more gains before the end of the year, helped by conti...
Here Are The Companies That Have Profited The Most During Inflation
Getty Images When it comes to inflation, there’s no shortage of blame to go around. First, the pandemic broke the global supply chain. Then stimulus payments set off a frenzy of consumer spending at...
Buy Merck And Eli Lilly
Photographer: Michael Nagle/Bloomberg © 2022 Bloomberg Finance LP The coming week is post options expiration week in October. The histogram below tells us that this week has a bearish tinge. S&P 5...
Moderna Stock Takes Off on Cancer Vaccine News
Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...
What Stocks May Do Well As The Fed Tightens
Federal Reserve Board Chairman Jerome Powell(Photo by Alex Wong/Getty Images) Getty Images He wasn’t kidding. Jerome Powell, chairman of the Federal Reserve Board, said Friday that the Fed’s Open Mark...
Merck Looks Attractive, With or Without Seagen
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple ...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
Merck in Advanced Talks to Buy Biotech Company Seagen
The regulatory concerns associated with the potential deal between Merck and Seagen may attract antitrust scrutiny from regulators. American multinational pharmaceutical company Merck & Co Inc (N...
Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck
Seagen (SGEN) – Get Seagen Inc. Report shares powered higher Thursday following a report from the Wall Street Journal that it’s in advanced takeover talks with drugmaker Merck & Co. ...
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion
Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
Merck & Co. is in advanced talks to acquire Seagen and is aiming to agree on a purchase of the cancer biotech in the next few weeks, according to people familiar with the matter, in a deal that co...
In A Sour Market, These 5 Stocks Have Been Sweet
An Exxon Mobil gas station. Photo by Kena Betancur/VIEWpress/Corbis via Getty Images Corbis via Getty Images While most stocks have nosedived this year, a few have gained altitude. Many, but by no mea...
Merck Pushes Forward With Potential Deal for Seagen
Merck & Co. is pushing forward with a potential deal for biotech Seagen Inc., according to people familiar with the matter, in what would be one of the largest takeovers of the year. The Wall Stre...
F-star Surges 60% On $161 Mln Acquisition Offer By Chinese Billionaire Family’s Sino Biopharmaceutical
Gains in economic development and income have turned China into one of the world’s largest markets … [+] for pharmaceuticals and spawned home-grown industry heavyweights. (Photo by Kevin F...
Merck Brings in Big Money
And the pharmaceutical company could rise even more due to strong sales growth and a healthy dividend. But another likely reason is Big Money lifting the stock. Big Money Loves Merck So, what’s Big Mo...